Search Press releases Keywords From To 9 Aug 2024 Transparency notification Goldman Sachs Read More 8 Aug 2024 Transparency notification Goldman Sachs Read More 7 Aug 2024 Transparency notification Goldman Sachs Read More 5 Aug 2024 UCB announces European Commission approval for 320 mg device presentations of BIMZELX[®]▼(bimekizumab) Read More 25 Jul 2024 Strong Start into UCB’s Decade of Growth Read More 28 Jun 2024 Acquisition of own shares Read More Pagination First page Previous page Previous … Page 20 Page 21 Page 22 Page 23 Current page 24 Page 25 Page 26 Page 27 Page 28 … Page 24 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe